Trastuzumab in HER2-negative early breast cancer as adjuvant treatment for circulating tumor cells (CTCs) (Treat CTC).Michail Ignatiadis,C Messina, S Litiere,Dimitris Mavroudis, C Dittrich,A Kong,Wolfgang Janni,Christos Sotiriou,Martine Piccartgebhart,Jeanyves Pierga,Brigitte RackCANCER RESEARCH(2014)引用 1|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要